Calcium Gluconate Market Report 2026

The calcium gluconate market size has grown strongly in recent years. It will grow from $118.01 billion in 2025 to $126.96 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing prevalence of calcium deficiency, rising cases of osteoporosis among elderly, growing hospital and clinical infrastructure, expansion of pharmaceutical distribution networks, increasing awareness about bone health.

The calcium gluconate market size is expected to see strong growth in the next few years. It will grow to $165.39 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for nutraceuticals and dietary supplements, innovations in injectable calcium formulations, expansion of geriatric care and pediatric healthcare, adoption of preventive healthcare strategies, growth of emerging markets in asia-pacific. Major trends in the forecast period include rising incidence of hypocalcemia, growth in osteoporosis awareness programs, increasing adoption of intravenous supplements, expansion of nutraceutical and functional foods, development of pediatric and geriatric calcium formulations.

The rising prevalence of osteoporosis is anticipated to drive expansion in the calcium gluconate market. Osteoporosis is a condition marked by diminished bone density and fragility, heightening fracture susceptibility. Cases of osteoporosis are climbing because of inactive lifestyles, insufficient calcium consumption, hormonal shifts, and aging-related bodily changes. The calcium gluconate market aids osteoporosis treatment by supplying supplemental calcium to enhance bone durability and lower fracture chances. For instance, in March 2025, the British Pharmacological Society, a UK-based association, reported that in 2023, most patients on osteoporosis therapies were women: 90.9% for denosumab, 80.8% for bisphosphonates, 98.9% for SERMs, 99% for tibolone, and 86.8% for teriparatide. Thus, the growing osteoporosis incidence is fueling calcium gluconate market growth.

Rising healthcare spending is anticipated to boost the calcium gluconate market in the future. Healthcare encompasses the structured network of medical care, experts, infrastructure, and assets designed to sustain and enhance people's physical and mental health. This spending is climbing because of aging demographics, rising rates of chronic illnesses, progress in medical innovations, and greater expectations for superior care services. The calcium gluconate market aids these demands by offering an essential remedy for disorders linked to calcium deficiency, such as hypocalcemia, heart-related issues, and specific poisonings. For instance, in 2024, per projections from the Office for Budget Responsibility (OBR) and the UK Treasury - a UK-based independent public entity - the UK's allocated health budget is expected to hit £192 billion ($244.43 billion) for 2024/25, up from £182 billion ($231.7 billion) in 2022/23. Thus, escalating healthcare expenditures are fueling expansion in the calcium gluconate market.

Major companies in the calcium gluconate market are prioritizing the creation and regulatory approval of innovative calcium gluconate drug formulations to enhance treatment access, deliver superior therapeutic solutions, and better manage calcium deficiencies along with associated acute disorders; this process involves a multi-phase journey encompassing discovery, preclinical assessments, clinical trials, and regulatory scrutiny to confirm a drug's safety, efficacy, and adherence to health agency requirements prior to patient use - for instance, in September 2023, Amneal Pharmaceuticals Inc., a U.S.-based firm specializing in generics and specialty pharmaceuticals, secured U.S. FDA approval via an abbreviated new drug application (ANDA) for calcium gluconate in sodium chloride injection, which earned Competitive Generic Therapy status with 180-day exclusivity and is available in 1000 mg/50 mL and 2000 mg/100 mL small-volume parenteral bags for treating acute symptomatic hypocalcemia in pediatric and adult patients.

Major companies operating in the calcium gluconate market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, Solvay, Viatris Inc., Baxter International Inc., Fresenius Kabi USA, Hikma Pharmaceuticals Inc., Amneal Pharmaceuticals Private Limited, Amphastar Pharmaceuticals, Jost Chemical Co., American Regent Inc., Coyne Chemical, Anhui Xingzhou Medicine Food Co. Ltd., Westco Chemicals Inc., Noah chemicals, ND Biotech Pvt Ltd, Global Calcium Private Limited, Foodchem, Pharma Cure Laboratories, Nivagen Pharmaceuticals Inc., Tianyi Food Additives Co. Ltd.

Europe was the largest region in the calcium gluconate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcium gluconate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the calcium gluconate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the calcium gluconate market by increasing the cost of imported raw materials and active pharmaceutical ingredients, thereby affecting production costs for pharmaceutical and nutraceutical manufacturers. The intravenous and oral supplement segments, particularly in regions like north america and europe that rely on imports, are most impacted. However, tariffs have also incentivized local manufacturing and sourcing, promoting domestic production capacities and innovation in cost-effective formulations, potentially benefiting regional suppliers in the long term.

The calcium gluconate market research report is one of a series of new reports that provides calcium gluconate market statistics, including calcium gluconate industry global market size, regional shares, competitors with a calcium gluconate market share, detailed calcium gluconate market segments, market trends and opportunities, and any further data you may need to thrive in the calcium gluconate industry. This calcium gluconate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Calcium gluconate serves as a mineral supplement for treating or preventing calcium deficiencies and managing issues like hypocalcemia, osteoporosis, and specific muscle spasms. It functions by restoring the body's calcium reserves, which support bone strength and muscle performance. Doctors often give it intravenously or orally to normalize blood calcium levels.

The primary forms of calcium gluconate include liquid, tablet, powder, and gel. Liquid describes substances that flow easily and conform to their container's shape, known for their pourability and ability to adapt to the container's form. Available grades encompass pharmaceutical grade and food grade, applied in areas like food and beverage production, pharmaceuticals, nutraceuticals, cosmetics and personal care, and additional uses. End uses cover emulsifier, bulking agent, and thickening agent.

The calcium gluconate market consists of sales of oral supplementation, calcium D-gluconate monohydrate, calcium D-gluconate gel and other injectable solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.